Showing results (411-420 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|January 30, 2022
Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of ImmunotherapyMelina E Marmarelis, Yu-Xiao Yang, Wei-Ting Hwang, et al.
Clinical Lung Cancer|April 25, 2022
Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for ManagementRemi Veillon, Hiroshi Sakai, Xiuning Le, et al.
Clinical Lung Cancer|March 21, 2022
Active Surveillance for Early Stage Lung CancerRyan G Payne, Christopher J Anker, Brian L Sprague, et al.
Clinical Lung Cancer|September 11, 2018
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerDwight H Owen, Lai Wei, Erin M Bertino, et al.
Clinical Lung Cancer|May 28, 2019
Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum ChemotherapyLee Schwartzberg, Beata Korytowsky, John R Penrod, et al.
Clinical Lung Cancer|October 13, 2018
Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and PerspectivesRobert Pirker, Martin Filipits
Clinical Lung Cancer|May 8, 2019
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life CohortElizabeth Dudnik, Jair Bar, Nir Peled, et al.
Clinical Lung Cancer|July 8, 2019
Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS CohortSolenn Brosseau, Claire Danel, Arnaud Scherpereel, et al.
Clinical Lung Cancer|April 8, 2022
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and PemetrexedChristine A Ciunci, Jacob B Reibel, Tracey L Evans, et al.
Clinical Lung Cancer|October 12, 2019
Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based StudyConnor J Kinslow, Michael S May, Anjali Saqi, et al.
Pageof 234